97
Views
13
CrossRef citations to date
0
Altmetric
Editorial

How to accelerate biomaterial development? Strategies to support the application of novel polymer-based biomaterials in implantable devices

&
Pages 533-537 | Published online: 09 Jan 2014

References

  • Weigel T, Schinkel G, Lendlein A. Design and preparation of polymeric scaffolds for tissue engineering. Expert Rev. Med. Devices3, 835–851 (2006).
  • Groth T, Lendlein A. Layer-by-layer deposition of polyelectrolytes – a versatile tool for the in vivo repair of blood vessels. Angew. Chem. Int. Ed.43(8), 926–928 (2004).
  • Jung F, Wischke C, Lendlein A. Degradable, multifunctional cardiovascular implants: challenges and hurdles. MRS Bull.35(8), 607–613 (2010).
  • Scharnagl N, Lee S, Hiebl B, Sisson A, Lendlein A. Design principles for polymers as substratum for adherent cells. J. Mater. Chem.20(40), 8789–8802 (2010).
  • Sobhi H, Matthews ME, Grandy B, Masnovi J, Riga AT. Selecting polymers for medical devices based on thermal analytical methods. J. Therm. Anal. Calorim.93(2), 535–539 (2008).
  • Lendlein A. Polymers for implants with biomedical applications. Chem. Unserer Zeit33(5), 279–295 (1999).
  • Straley KS, Foo CWP, Heilshorn SC. Biomaterial design strategies for the treatment of spinal cord injuries. J. Neurotrauma27(1), 1–19 (2010).
  • Bettinger CJ. Biodegradable elastomers for tissue engineering and cell-biomaterial interactions. Macromol. Biosci.11(4), 467–482 (2011).
  • Lendlein A, Neffe AT, Pierce BF, Vienken J. Why are so few degradable polymeric biomaterials currently established in clinical applications?. Int. J. Artif. Organs34(2), 71–75 (2011).
  • Shastri VP, Lendlein A. Materials in regenerative medicine. Adv. Mater.21(32–33), 3231–3234 (2009).
  • Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharmaceut.364(2), 298–327 (2008).
  • Verreck G, Decorte A, Heymans K et al. The effect of supercritical CO2 as a reversible plasticizer and foaming agent on the hot stage extrusion of itraconazole with EC 20 cps. J. Supercrit. Fluids40(1), 153–162 (2007).
  • Luetzow K, Klein F, Weigel T, Apostel R, Weiss A, Lendlein A. Formation of poly(ε-caprolactone) scaffolds loaded with small molecules by integrated processes. J. Biomech.40, S80–S88 (2007).
  • Wischke C, Neffe AT, Steuer S, Lendlein A. Comparing techniques for drug loading of shape-memory polymer networks – effect on their functionalities. Eur. J. Pharmaceutical Sci.41(1), 136–147 (2010).
  • Bertmer M, Buda A, Blomenkamp-Hofges I, Kelch S, Lendlein A. Biodegradable shape-memory polymer networks: characterization with solid-state NMR. Macromolecules38(9), 3793–3799 (2005).
  • Kummerlowe G, Auernheimer J, Lendlein A, Luy B. Stretched poly(acrylonitrile) as a scalable alignment medium for DMSO. J. Am. Chem. Soc.129(19), 6080–6081 (2007).
  • Hofmann D, Entrialgo-Castano M, Kratz K, Lendlein A. Knowledge-based approach towards hydrolytic degradation of polymer-based biomaterials. Adv. Mater.21(32–33), 3237–3245 (2009).
  • Han XX, Pan JZ. Polymer chain scission, oligomer production and diffusion: a two-scale model for degradation of bioresorbable polyesters. Acta Biomater.7(2), 538–547 (2011).
  • Kulkarni A, Reiche J, Hartmann J, Kratz K, Lendlein A. Selective enzymatic degradation of poly(ε-caprolactone) containing multiblock copolymers. Eur. J. Pharm. Biopharm.68(1), 46–56 (2008).
  • Rickert D, Lendlein A, Schmidt AM et al.In vitro cytotoxicity testing of AB-polymer networks based on oligo(ε-caprolactone) segments after different sterilization techniques. J. Biomed. Mater. Res. Part B Appl. Biomater.67B(2), 722–731 (2003).
  • Tronci G, Neffe AT, Pierce BF, Lendlein A. An entropy-elastic gelatin-based hydrogel system. J. Mater. Chem.20(40), 8875–8884 (2010).
  • Lendlein A, Neuenschwander P, Suter UW. Tissue-compatible multiblock copolymers for medical applications, controllable in degradation rate and mechanical properties. Macromol. Chem. Phys.199(12), 2785–2796 (1998).
  • Lendlein A, Colussi M, Neuenschwander P, Suter UW. Hydrolytic degradation of phase-segregated multiblock copoly(ester urethane)s containing weak links. Macromol. Chem. Phys.202(13), 2702–2711 (2001).
  • Kelch S, Steuer S, Schmidt AM, Lendlein A. Shape-memory polymer networks from oligo[(ε-hydroxycaproate)-co-glycolate]dimethacrylates and butyl acrylate with adjustable hydrolytic degradation rate. Biomacromolecules8(3), 1018–1027 (2007).
  • Lendlein A, Behl M, Hiebl B, Wischke C. Shape-memory polymers as a technology platform for biomedical applications. Expert Rev. Med. Devices7(3), 357–379 (2010).
  • Behl M, Razzaq MY, Lendlein A. Multifunctional shape-memory polymers. Advanced Materials22(31), 3388–3410 (2010).
  • Hiebl B, Rickert D, Fuhrmann R, Jung F, Lendlein A, Franke RP. Tissue integration of two different shape-memory polymers with poly(ε-caprolactone) switching segment in rats. Mater. Res. Soc. Symp. Proc.1140, 143–149 (2009).
  • Rickert D, Scheithauer MO, Coskun S, Kelch S, Lendlein A, Franke RP. The influence of a multifunctional, polymeric biomaterial on the concentration of acute phase proteins in an animal model. Clin. Hemorheol. Micro.36(4), 301–311 (2007).
  • Neffe AT, Hanh BD, Steuer S, Lendlein A. Polymer networks combining controlled drug release, biodegradation, and shape memory capability. Adv. Mater.21(32–33), 3394–3398 (2009).
  • Wischke C, Neffe AT, Steuer S, Engelhardt E, Lendlein A. AB-polymer networks with cooligoester and poly(n-butyl acrylate) segments as a multifunctional matrix for controlled drug release. Macromol. Biosci.10(9), 1063–1072 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.